Literature DB >> 35918143

The Advancing American Kidney Health Initiative: The Challenge of Overcoming the Status Quo.

Paul T Conway1, Nieltje Gedney2, Shuvo Roy3, William H Fissell4.   

Abstract

Entities:  

Keywords:  United States; dialysis; kidney transplantation; nephrology; organ transplant; peritoneal dialysis; quality of life; renal dialysis; transplantation

Year:  2022        PMID： 35918143      PMCID： PMC9529178          DOI： 10.1681/ASN.2022040510

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  4 in total

Review 1.  How will gene therapy apply to the kidney in the 21st century?

Authors:  B C Kone
Journal:  Semin Nephrol       Date:  2000-01       Impact factor: 5.299

2.  Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop.

Authors:  Allison Tong; Braden Manns; Brenda Hemmelgarn; David C Wheeler; Nicole Evangelidis; Peter Tugwell; Sally Crowe; Wim Van Biesen; Wolfgang C Winkelmayer; Donal O'Donoghue; Helen Tam-Tham; Jenny I Shen; Jule Pinter; Nicholas Larkins; Sajeda Youssouf; Sreedhar Mandayam; Angela Ju; Jonathan C Craig
Journal:  Am J Kidney Dis       Date:  2016-08-03       Impact factor: 8.860

3.  The Advancing American Kidney Health Initiative: The Challenge of Measuring Success.

Authors:  Robert R Quinn; Ngan N Lam; Pietro Ravani; Matthew J Oliver; Peter G Blake; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2022-03-29       Impact factor: 14.978
  4 in total
  1 in total

1.  Response to "The Advancing American Kidney Health Initiative: The Challenge of Overcoming the Status Quo" and "The Advancing American Kidney Health Initiative: Do Not Let 80% Distract Us from the Fact that We Can Do Better".

Authors:  Robert R Quinn; Ngan N Lam; Pietro Ravani; Matthew J Oliver; Peter G Blake; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2022-08-02       Impact factor: 14.978
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.